Julex Capital Management’s Halozyme HALO Stock Holding History

Julex Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-137	Closed	-$2.21K	–	169
2019 Q1	$2.21K	Buy	+137	New	+$2.22K	﹤0.01%	97

Other funds holding HALO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Julex Capital Management's HALO Position: Q2 2019 in Review

Julex Capital Management sold out of Halozyme (HALO) in Q2 2019, closing a stake of 137 shares — an estimated $2.21K sold.

Julex Capital Management first reported a position in HALO in Q1 2019 and held it in 1 quarter. The position peaked at $2.21K in Q1 2019. 202 funds tracked by Wall St. Rank hold HALO as of Q2 2019.

Julex Capital Management reported no remaining Halozyme position as of Q2 2019 after selling out during the quarter.
Julex Capital Management sold 137 Halozyme shares in Q2 2019, an estimated $2.21K.
Julex Capital Management first reported a position in Halozyme in Q1 2019 and held it in 1 quarter.
Julex Capital Management's Halozyme position peaked at $2.21K in Q1 2019.
202 funds tracked by Wall St. Rank held Halozyme as of Q2 2019.

Based on Julex Capital Management's 13F filing for Q2 2019, filed 29 Oct 2019.